Drug
Cudc-101 clinical trials
Also written CUDC-101.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Development codes
- CUDC-101
- 4
Studies by the year they started
4 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Curis, Inc. (4)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses cudc-101 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck CancerCompletedPhase 1Curis, Inc.NCT01384799Written as CUDC-101
- A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of CUDC-101 in Patients With Advanced Solid TumorsCompletedPhase 1Curis, Inc.NCT00728793Written as CUDC-101
- Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Orally Administered CUDC-101 in Cancer PatientsTerminatedPhase 1Curis, Inc.NCT01702285Written as CUDC-101
- A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer TumorsCompletedPhase 1Curis, Inc.NCT01171924Written as CUDC-101
Codes
What other systems call cudc-101 · ClinicalTrials.gg INT005631
- UNII (FDA) 1A7Y9MP123CUDC-101Confirmed FDA, Wikidata
- Wikidata Q27076925cudc-101Confirmed FDA, Wikidata
- NCI Thesaurus C78850HDAC/EGFR/HER2 Inhibitor CUDC-101One source FDA
- DrugBank DB12174One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 1A7Y9MP123 | CUDC-101 | Confirmed FDA, Wikidata |
| Wikidata | Q27076925 | cudc-101 | Confirmed FDA, Wikidata |
| NCI Thesaurus | C78850 | HDAC/EGFR/HER2 Inhibitor CUDC-101 | One source FDA |
| DrugBank | DB12174 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.